Harvard University’s endowment has participated in a funding round for the robo-advisory platform.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Oxford University Innovation has revealed it launched 37 new companies between April 2020 and March 2021, its best run yet.

Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.

Eddyfi/NDT has agreed to purchase UCL spinout Senceive for an undisclosed amount.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.

Huber+Suhner has acquired Cambridge spinout RoadMap Systems for an undisclosed amount.